Postepizootic persistence of Venezuelan equine encephalitis virus, Venezuela

Postepizootic persistence of Venezuelan equine encephalitis virus, Venezuela

Juan-Carlos Navarro

Five years after the apparent end of the major 1995 Venezuelan equine encephalitis (VEE) epizootic/epidemic, focal outbreaks of equine encephalitis occurred in Carabobo and Barinas States of western Venezuela. Virus isolates from horses in each location were nearly identical in sequence to 1995 isolates, which suggests natural persistence of subtype IC VEE virus (VEEV) strains in a genetically stable mode. Serologic evidence indicated that additional outbreaks occurred in Barinas State in 2003. Field studies identified known Culex (Melanoconion) spp. vectors and reservoir hosts of enzootic VEEV but a dearth of typical epidemic vectors. Cattle serosurveys indicated the recent circulation of enzootic VEEV strains, and possibly of epizootic strains. Persistence of VEEV subtype IC strains and infection of horses at the end of the rainy season suggest the possibility of an alternative, cryptic transmission cycle involving survival through the dry season of infected vectors or persistently infected vertebrates.


Venezuelan equine encephalitis (VEE) is a reemerging, mosquitoborne viral disease of humans and equines (1). Equines serve as highly efficient amplification hosts for mosquitoborne transmission of 2 VEE virus (VEEV) epidemic subtypes, IAB and IC. Humans become infected primarily through the bites of the large numbers of mosquitoes that can be infected by viremic horses. Enzootic VEEV strains of variants ID and IE, closely related antigenically and genetically to each other and to variants IAB and IC, circulate in lowland tropical forests and swamps among small mammals but are incapable of equine amplification to cause epidemics (2).

After a long period of inactivity from 1973 to 1992, recent outbreaks in Venezuela (3,4), Colombia (5), and Mexico (6) underscore the continued threat of VEE in the Americas. Because recent outbreaks have occurred sporadically, often with many intervening years of epidemic inactivity, the origin of strains of VEEV subtypes IAB and IC was enigmatic for many years. Of several hypotheses proposed (7), only 2 have been supported by antigenic and genetic comparisons of VEEV strains and experimental studies. The first hypothesis, suggested by sequence data, is that some epidemics that occurred between the first isolation of VEEV in 1938 and the last outbreak involving a strain of the IAB subtype in 1973 resulted from the use of incompletely inactivated vaccines produced from strains of VEEV subtype IAB (8). The lack of VEEV subtype IAB outbreaks since inactivated virus vaccines were replaced by the TC-83 attenuated vaccine strain (a subtype IAB virus) in the early 1970s also supports this hypothesis. The second hypothesis, supported by genetic studies, is that epizootic/epidemic (henceforth called epidemic) subtype IAB and IC VEEV strains arise through mutation from enzootic subtype ID VEEV strains (9). The strongest such evidence links a small, 1992-93 Venezuelan VEE outbreak caused by a subtype IC virus strain to sympatric strains of enzootic subtype ID virus (3,10).

The last major VEE epidemic began in April 1995 in the northern Venezuelan state of Falcon and spread throughout most of northern Venezuela and into La Guajira peninsula of northeastern Colombia to cause [approximately equal to] 75,000-100,000 human cases with [approximately equal to] 300 deaths (Figure 1) (4,5). Although the total number of equine cases was not reported, it was probably of a similar order of magnitude. The last equine and human cases were reported in December 1995 in Trujillo, Portuguesa, Cojedes, and Guarico States of Venezuela. After the apparent end of the 1995 outbreak, no confirmed epidemic or epizootic VEE occurred in South America for >4 years.


During December 1999 and February 2000, small, focal outbreaks of equine encephalitis were reported during the end of the rainy season and beginning of the dry season in Carabobo and Barinas States of Venezuela (Figure 1). Similar outbreaks occurred in Barinas State during October 2003. Clinical case descriptions, viral genetic studies, and preliminary surveillance in the region suggested persistence of VEEV subtype IC after 1995 in a cryptic transmission cycle.

Materials and Methods

Collection of Animal Samples

Arboviral surveillance was conducted in 2 regions of Barinas State: 1) Zamora and Obispos Counties and 2) Arismendi County (Figure 1). Four farms were studied in Zamora and Obispos Counties from April 2001 to October 2003: 1) El Relampago (7[degrees]57’24″N, 70[degrees]59’20″W); 2) El Porvenir (7[degrees]49′-8[degrees]49’N; 70[degrees]37′-70[degrees]55’W); 3) La Grandeza (7[degrees]50’13″N, 70[degrees]44’25″W), and 4) Boca de Quiu (7[degrees]51′-57″N, 70[degrees]43’52″W). In Arismendi County, studies occurred in October 2003, at the end of the outbreak, on 4 farms: 1) Los Mesones (8[degrees]31’52″N, 68[degrees]21’49” W); 2) Mis Cantares (8[degrees]24’09″N, 68[degrees]17″93″W); 3) Don Eduardo (8[degrees]28’36″N, 68[degrees]21’94”), and 4) La Espuela (8[degrees]28″72″N, 68[degrees]21″68″W, including equines obtained from El Diamante). These farms, typical of the region, focus mainly on cattle production; equines are maintained for herding.

At each site, Syrian golden hamsters were exposed in coquito cages (11) for 7 days. Cages were suspended 1.2-1.5 m above the ground in transects at 20- to 25-m intervals, and hamsters were inspected and fed carrots daily. Blood samples were collected by cardiac puncture from moribund hamsters and from those surviving exposure; heart and spleen samples were then dissected and preserved in liquid nitrogen. The maintenance and care of animals complied with guidelines of the University of Texas Medical Branch and the Instituto Nacional de Higiene.

Parallel to the hamster transects, Sherman and Tomahawk traps were used for collecting small mammals, as described previously (12). Animals were bled by cardiac puncture and identified by using taxonomic keys (13,14).

Mosquito Collections

Mosquitoes were collected with CDC light traps (15) baited with dry ice and suspended [approximately equals to] 1.5 m above the ground. Mosquitoes were identified by using taxonomic keys (16-19) and reference collections (20).

Virus Isolations and Identification

Sera and tissues from equines, sentinel hamsters, and wild rodents were injected into 1- to 3-day-old mice or African green monkey kidney (Vero) cells for virus isolation. Viruses indicated by mouse deaths or cytopathic effects in cell culture were identified by hemagglutination inhibition (HI) tests. Subtypes of the VEEV isolates were determined by immunofluorescence by using monoclonal antibodies (MAbs), as described previously (21), and by amplifying by reverse transcriptase-polymerase chain reactions (RT-PCR) a portion of the PE2 envelope glycoprotein precursor gene, followed by sequencing and phylogenetic analyses, as described previously (22).

Genetic Analyses of Virus Isolates

The complete genomes or partial PE2 envelope glycoprotein precursor sequences of VEEV strains were amplified by RT-PCR using Superscript reverse transcriptase (BRL, Bethesda, MD, USA) and Pfu polymerase (Stratagene, La Jolla, CA, USA), as described previously (23). After electrophoresis, amplicons were extracted from 1% agarose gels and sequenced directly by using previously described primers (23) and the Applied Biosystems (Foster City, CA, USA) Prism automated DNA sequencing kit to produce consensus sequences. Genomic sequences, excluding the 5′ terminal 20 nucleotides (nt) derived from the primer, or PE2 sequences, were submitted to the GenBank library under accession numbers AY973944 and AY986475. Sequences were aligned with homologous VEEV sequences in the GenBank library and analyzed by using neighbor-joining and maximum parsimony methods implemented in the PAUP 4.0 software package (24) and Bayesian methods with MrBayes 3 (25).

Antibody Detection and Characterization

Serum samples were screened for VEEV antibodies by using HI with antigens prepared from the TC-83 attenuated virus vaccine strain and the South American eastern equine encephalitis virus strain C-49 (26). Antibodies from serum samples with titers [greater or equal to] 1:20 were confirmed by using 80% plaque reduction neutralization tests (PRNTs). To determine the VEEV subtypes that produced reactive sera, a blocking enzyme-linked immunosorbent assay (ELISA) with purified VEEV antigens and enzootic- or epidemicspecific MAbs (21) was used, as described previously (27). Negative control serum specimens were obtained from animals in non-disease-endemic locations with no history of VEE.


Description of Outbreaks

In February 2000, the Venezuelan Animal Health Service received a report of an equine encephalitis outbreak, consistent with VEE, on the Bella Vista farm in the Curito Abajo area of Zamora County, Barinas State. Simultaneously, another outbreak occurred on the Los Cerros farm in Obispos County (Figure 1). Five serum specimens were collected from stablemates of affected horses on the Bella Vista farm; 2 yielded VEEV isolates. One brain sample collected at necropsy during April 2000 on the Los Cerros farm yielded VEEV. Suspected VEE was reported in Obispos, Zamora, Pedraza, and Miranda municipalities before these VEEV isolates were confirmed at the Instituto Nacional de Investigaciones Agropecuarias in April 2000. In addition, retrospective examination of epidemiologic records showed suspected VEE cases in Zamora County (Curito Abajo) since December 1999.

After the February 2000 outbreaks, 8 additional foci with 35 fatal equine cases were reported: 3 outbreaks in Zamora (15 deaths), 2 in Obispos (13 deaths), 2 in Pedraza (7 deaths), and 1 (no deaths) in Sucre County. Regional equine vaccination coverage with the strain TC-83 attenuated virus vaccine was 24% before the outbreaks, and additional vaccination initiated around all apparent foci in early 2000 increased coverage to 51%.

A geographically distant equine case consistent with VEE occurred in April 2000 in Carabobo State (Figure 1). The affected horse had been moved from south Guarico State (borders Obispos County of Barinas State) 10 days before onset of disease. Virus was isolated from its brain after euthanization and from the serum of a recently vaccinated stablemate. Another equine death had occurred on the same farm, but the horse had been incinerated before the cause of death could be confirmed.

Another outbreak consistent with VEE was reported in October 2003 in northeastern Barinas State around the town of Arismendi and along the nearby Guanare River basin (Figure 1). Because the affected farms were difficult to access and farmers did not initially report the cases to avoid equine quarantines, samples from affected horses were not obtained.

Equine Serology

A total of 619 equine serum specimens from 8 different municipalities in Barinas State were tested for VEEV and eastern equine encephalitis virus (EEEV) antibodies by using HI (Table 1). Zamora and Pedraza municipalities showed the highest rates of VEEV seropositivity (44% and 48%, respectively); although vaccination was ongoing at the time of sampling, and some seropositivity undoubtedly resulted from vaccination, vaccine coverage of only =24% suggested that some horses were naturally infected. The blocking ELISA (27) cannot distinguish between strain TC-83 and subtype IC VEEV infections, so the VEEV strain origins of equine antibodies could not be determined.


To investigate circulation of VEEV, small mammals, known to be reservoir hosts of VEEV, and mosquitoes were trapped at 4 sites near the equine cases. Bovines [less than or equal to] 2 years of age that lived on the same farm for their entire life were bled as sentinels to detect recent VEEV circulation. The region of the first outbreak in 2000 included a part of Zamora and Obispos Counties, formerly included in the Ticoporo Forest Reserve (previously a rainforest, 8[degrees]12’N/ 70[degrees]56’W) between the Quiu and Michay Rivers, on the border between the western Llanos (plains and savannas) and the southern Andes Mountains. This area has been deforested for timber, cattle ranching, and crop farming, leaving only forest fragments and gallery forests with slopes of <l% grade and an altitude of [approximately equal to] 200 m. The forested area decreased from 186,000 hectares (ha) in 1955 to 5,000 ha in 2002 ( 1124/ecobreves.shtml).

The Barinas State rainy season is from April to December, and the dry season is from January to March, with mean temperatures of 22[degrees]C to 30[degrees]C. Annual precipitation averages 1,729-1,995 mm. The flora are typical of the Llanos and lowland Andean Mountains, including Ceiba pentadra, Bombacopsis quinata, Spondia mombin, Chrysophyllum sericeum, Pouteria anibaefolia, Guazuma tomentosa, Attalea maracaibensis, and Roystonea venezuela. During the end of the rainy season, rivers flood adjacent lowland forests and generate habitat for water lettuce (Pistia stratiotes), a floating plant used as a breeding site by some Culex (Melanoconion) mosquito species.

The region of the second VEE outbreak in 2000 (Arismendi County) also comprises lowland savannas in the Guanare River basin and includes extensive cattle production and fragmented forests resulting from deforestation. This part of Barinas State borders Guarico, Cojedes, and Portuguesa States to the north and northwest, and Apure State to the south (Figure 1). The flora is characteristic of lowland Llanos (95-m altitude) and flooded savannas: Copernicia tectorum (Llanos palms), Hymenachne amplexicaulis, Leersia hexandra, and Luziola spruceana. The climate is similar to that described above.

Mammal Collections

A total of 130 small mammals were collected during 6,600 trap-nights, for a success rate of 1.9%. The captures and serologic data are shown in Table 2. The spiny rat (Proechimys guairae) and the cotton rat (Sigmodon hispidus), both belonging to known enzootic VEEV reservoir genera (12,28,29), as well as the cane mouse (Zygodontomys brevicauda), were abundant at most sites. No virus was isolated from wild mammals; HI antibodies to VEEV were detected in 4 (6.8%) of 58 P guairae, 1 (25%) of 4 Didelphis marsupialis, and 1 (6.6%) of 15 S. hispidus. However, HI titers were low (<1:20), and none was confirmed by PRNT (<20). No EEEV-reactive antibodies were detected. These results suggest either very low VEEV antibody titers in some rodents or nonspecific HI reactivity.

Bovine Serology

Bovines are effective VEE sentinels because they are naturally infected and seroconvert but no disease develops and they are not vaccinated (30). We bled cattle [less than or equal to] 2 years of age that had resided on the same farm for their entire life. The Zamora site showed no evidence of bovine seropositivity, with 0 of 4 positive for VEEV antibodies in May and 0 of 20 in September 2003 (Table 2). However, the Arismendi site had a 25% bovine VEEV seropositivity rate (12/48) from October to November 2003, and all positive serum samples were negative for EEEV. To determine whether the seropositive cattle were infected by enzootic or epidemic (subtype IC) VEEV strains, we used a blocking ELISA that distinguishes antibodies based on their ability to block the reaction of subtype-specific monoclonal antibodies (27). Five of the 8 PRNT-positive bovine serum specimens had consistently higher blocking activity against the enzootic virus-specific MAb, indicating exposure to enzootic VEE-complex alphaviruses (Table 3). However, 2 samples (166, 167) had similar blocking activities against both enzootic and epidemic virus-specific MAbs, which suggests either infection with both enzootic and epidemic VEEV phenotypes or nonspecific reactivity against 1 subtype.

Mosquito Collections

Three C[O.sub.2]-baited CDC light traps were stationed for 2 consecutive days on each farm to assess possible VEEV vectors as follows: May, June, and September-October, 2003 (Zamora County); October-November 2003 (Arismendi); and December 2003 (Obispos). These months correspond to the dry season and the rainy season. Maximum catches were obtained in December 2002 and November 2003, at the end of the rainy season. A total of 21 mosquito species and 5 unidentified taxa (to species level) were collected (Table 4). The most abundant species captured were Cx. (Melanoconion) dunni, Mansonia titillans, Cx. (MeL ) spissipes, Coquillettidia aribalzagae, Ae. scapularis, Cx. (Mel.) aikeni sensu lato (ocossa and panocossa), and Psorophora albipes. Also, a large number of unknown Cx. (Mel.) spp. belonging to the Melanoconion Section were captured. No viruses were isolated from mosquitoes; however, 2 of the most abundant species, Cx. ocossa and Cx. panocossa, have been incriminated as enzootic VEEV vectors and Ma. titillans and Ae. scapularis were implicated as potential bridge vectors that may export VEEV from sylvatic, enzootic foci in Venezuela (31). However, typical epidemic vectors such as Ae. taeniorhynchus and Ps. confinnis were not present.

Isolation and Genetic Analyses of VEEV Strains from Equines

Two equine brain specimens and 3 serum samples from stablemates yielded mouse deaths with CPE-inducing activity in brains. Antigenic analyses that used MAbs indicated that all isolates belonged to subtypes IAB/C. Four sequences of RT-PCR amplicons covering the PE2 gene were identical to the subtype IC strains 6119 and 3908 from the 1995 epidemic, and also to the subtype IC strains P676 and V198 from the 1962-64 epidemic (Table 5) (23). The exception was strain 254818, isolated from a stablemate of a deceased horse in Carabobo State after strain TC-83 vaccination was initiated; this strain had a PE2 sequence identical to that of strain TC-83 (32), with the exception of a single nucleotide difference at genome position 8845 that encoded a Lys to Met change at E2 amino acid position 115.

To increase phylogenetic resolution, the complete genomes (excluding the 5′ terminal 20 nt that incorporated PCR primers into amplicons) of representative strains from Carabobo (255010) and Barinas States (254934) were sequenced. The most closely related sequence to both isolates was strain 6119, isolated in May, soon after the beginning of the 1995 VEE epidemic in Falcon State. This strain differed from strains 255010 and 254934 by only 1 and 4 nt, respectively. Slightly more distantly related was strain 3908 from Zulia State in September 1995, followed by strains from the 1962-64 Venezuelan/Colombian epidemic. Only 1-nt difference among the year 2000 and 1995 VEEV isolates encoded an amino acid difference; strain 254934 had Lys at E2 position 199, whereas all other strains had Glu (Table 5).

Phylogenetic analyses that used all methods indicated that strain 6119 had a sequence identical to the predicted ancestor of strains 255010 and 254934, and branch lengths indicated interepidemic evolutionary rates of 1.7-7.0 x [10.sup.-5] substitutions/nucleotide/year. In contrast, during the 1995 outbreak, relative branch lengths of strains 6119 and 3908 indicated a faster evolutionary rate of 2.0 x [10.sup.4] substitutions/nucleotide/year. Relative rate analyses of the 1962-64 epidemic clade resulted in similar estimates of intraepidemic evolution from 2.2-4.4 x [10.sup.4] substitutions/nucleotide/year, similar to estimates of [approximately equal to] 3 x [10.sup.4] substitutions/nucleotide/year for enzootic VEEV in Venezuela (23). These data indicate that the subtype IC VEEV strains persisted in Venezuela from 1995 to 2000 in a genetically stable manner, with ca. 10-fold slower rates of nucleotide substitution than are estimated to occur during epidemic or enzootic circulation.


Of 5 major hypotheses proposed to explain the source(s) of strains of subtypes IAB and IC responsible for all major VEE outbreaks (7), 2 are supported by previous studies: 1) several of the later VEE outbreaks caused by subtype IAB strains were probably initiated by the use of incompletely inactivated vaccines produced from early, wild-type, equine-virulent isolates (8,33); and 2) all subtype IAB and IC strains evolved independently from an enzootic lineage of subtype ID VEEV that circulates in western Venezuela, Colombia, and northern Peru (2,22). Johnson and Martin (7) also hypothesized that epidemic strains might persist between outbreaks in cryptic transmission cycles that have been overlooked, despite postepidemic surveillance in the affected areas of Colombia (11,12) and Venezuela (12,34,35).

We report the first direct evidence that supports postepidemic circulation of epidemic VEEV. During 2000 in western Venezuela, 5 years after the apparent end of the 1995 epidemic, 4 isolates of VEEV nearly identical to 1995 strains were associated with equine encephalitis in Barinas and Carabobo States. Viral sequences had undergone virtually no evolutionary change during the interepidemic period, in contrast to epidemic and enzootic virus circulation, in which a relatively steady rate of nucleotide substitutions, on the order of 2-4 x [10.sup.4] substitutions/ nucleotide/year, occurs (23,36). From 1995 to 2000, the subtype IC strain underwent an [approximately equal to] 10-times slower evolution, which suggests less replication than normally occurs in rodent reservoir or equine amplification hosts and mosquitoes during horizontal transmission.

Our seroprevalence data from bovines also suggest that enzootic VEEV strains may have been circulating in the affected regions. Although we did not identify bovine serum that exhibited blocking activity solely against the epidemic virus-specific MAb, some samples reacted in both epidemic- and enzootic virus-specific ways. Larger samples of bovine and rodent serum are needed to more conclusively assess the subtype(s) of VEEV strains circulating in the region.

Although we could not identify the critical reservoir hosts and vectors that allow VEEV to persist in Barinas State, the occurrence of equine cases at the end of the rainy season and beginning of the dry season suggests fundamental differences from normal epidemic or enzootic circulation. Epidemic VEE generally occurs during the peak of the rainy season, when floodwater mosquitoes are abundant. Although mosquito surveillance was not conducted during the Barinas or Carabobo outbreaks, collections during the same season in 2001 indicated relatively small populations on the affected farms. Although our more recent mosquito collections included known enzootic VEEV vectors (Table 4), these mosquitoes are not known to transmit epidemic virus strains, and we did not detect VEEV antibodies in the rodents with which they are typically associated in sylvatic, enzootic foci. Typical epidemic vectors were not abundant in the affected regions. These results suggest the possibility that more xerophilic vectors other than mosquitoes might have been responsible for subtype IC VEEV maintenance and transmission to horses.

Ticks are susceptible to experimental infection by VEEV, although rates of oral and transtadial transmission tend to be low (37-39), and persistence for up to 171 days has been demonstrated. The effect of persistent tick infection on alphavirus genome stability has not been evaluated, but alphavirus infection of mosquitoes involves early replication for [approximately equal to] 1 week, followed by declining replication due to poorly understood modulating factors that probably include RNA interference (40). If similar mechanisms occur in infected ticks, long-term persistence could result in the levels of genetic stasis we observed in subtype IC VEEV from 1995 to 2000. To evaluate this hypothesis, more extensive surveillance designed to identify the vector(s) and reservoir host(s) in Barinas State is ongoing.

Our results also call into question previous estimates of alphavirus evolutionary rates that suggested a laboratory source for the 1995 Venezuelan epidemic. The inconsistency between the genetic stasis observed in subtype IC strains isolated from 1962-1964 versus 1995, and rates of nucleotide substitution observed during enzootic or epidemic VEEV circulation, suggested a laboratory source for the 1995 outbreak (23). The common use in Venezuela of antigens prepared from a 1963 strain (P676), from which active virus was isolated, and its similarity to the predicted progenitor of the 1995 outbreak also supported this hypothesis of a laboratory origin. We consider it highly unlikely that the year 2000 Carabobo and Barinas outbreaks resulted from laboratory strains because of the following factors: 1) in Venezuela, wildtype epidemic VEEV strains have largely been replaced for antigen preparation by the strain TC-83 vaccine virus to minimize the possibility of a laboratory-initiated outbreak; 2) the 2000 isolates do not group phylogenetically with strain P676 as the 1995 strains do (Figure 2); and 3) unlike Falcon state, where the 1995 outbreak began, the locations of the 2000 outbreaks are far from the diagnostic and vaccine production laboratories that work with VEEV. Also, the Instituto Nacional de Investigaciones Agropecuarias, where the year 2000 VEEV strains were isolated, had not worked with subtype IC VEEV for many months. Furthermore, the isolation of the strain TC-83 virus from a stablemate of the encephalitic horse at the Carabobo site during vaccination efforts argues against any laboratory contamination with a subtype IC strain. This evidence strongly suggests that the 2000 outbreaks involved naturally circulating VEEV strains that were maintained in a genetically stable state since 1995. Thus, based on genetic stasis and other factors, the previous conclusion that the 1995 outbreak may have had a laboratory origin, should be reevaluated. Since epidemic strains of VEEV can be maintained for at least 5 (1995-2000 or 2003) and possibly even 31 (1964-1995) years between epidemics, equine vaccination efforts and surveillance should be implemented continuously in Venezuela and Colombia.



We thank Nelson Moncada, Napoleon Leon, Lisandro Carrasco, J.R. Salazar, Wenli Kang for field and laboratory technical assistance; Gabriela Rangel-Diaz for professional assistance; Juan Martinez for map design; Alba Carrillo, Edita de Torrealba, Reina Benitez, and Luis Salinas for field logistic assistance; and farm owners J. Garcia, F. Perez, J. Perez and his wife, F. Umania, D. Baiza, O. Rojas, A. Bernal, L. Mora and Mora family, A. Sanchez, W. (Chicho) Nieves, and G. Hernandez for their hospitality.

This research was funded by National Institutes of Health grant AI48807. L.L.C. was supported by the James W. McLaughlin Fellowship Fund.


(1.) Walton TE, Grayson MA. Venezuelan equine encephalomyelitis. The arboviruses: epidemiology and ecology, Vol. IV. Boca Raton (FL): CRC Press; 1988. p. 203-31.

(2.) Weaver SC, Ferro C, Barrera R, Boshell J, Navarro JC. Venezuelan equine encephalitis. Annu Rev Entomol. 2004;49:141-74.

(3.) Rico-Hesse R, Weaver SC, de Siger J, Medina G, Salas RA. Emergence of a new epidemie/epizootic Venezuelan equine encephalitis virus in South America. Proc Natl Acad Sci U S A. 1995;92:5278-81.

(4.) Weaver SC, Salas R, Rico-Hesse R, Ludwig GV, Oberste MS, Boshell J, Tesh RB. Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. VEE Study Group. Lancet. 1996;348:436-40.

(5.) Rivas F, Diaz LA, Cardenas VM, Daza E, Bruzon L, Alcala A, et al. Epidemic Venezuelan equine encephalitis in La Guajira, Colombia, 1995. J Infect Dis. 1997;175:828-32.

(6.) Oberste MS, Fraire M, Navarro R, Zepeda C, Zarate ML, Ludwig GV, et al. Association of Venezuelan equine encephalitis virus subtype 1E with two equine epizootics in Mexico. Am J Trop Med Hyg. 1998;59:100-7.

(7.) Johnson KM, Martin DH. Venezuelan equine encephalitis. Adv Vet Sci Comp Med. 1974;18:79-116.

(8.) Weaver SC, Pfeffer M, Marriott K, Kang W, Kinney RM. Genetic evidence for the origins of Venezuelan equine encephalitis virus subtype IAB outbreaks. Am J Trop Med Hyg. 1999;60:441-8.

(9.) Greene IP, Paessler S, Austgen L, Anishchenko M, Brault AC, Bowen RA, et al. Envelope glycoprotein mutations mediate equine amplification and virulence of epizootic Venezuelan equine encephalitis virus. J Virol. 2005;79:9128-33.

(10). Wang E, Barrera R, Boshell J, Ferro C, Freier JE, Navarro JC, et al. Genetic and phenotypic changes accompanying the emergence of epizootic subtype IC Venezuelan equine encephalitis viruses from an enzontic subtype ID progenitor. J Virol. 1999;73:4266-71.

(11.) Dickerman RW, Cupp EW, Groot H, Alarcon AM, Cura E, Dickerman AW, et al. Venezuelan equine encephalitis virus activity in northern Colombia during April and May 1983. Bull Pan Am Health Organ. 1986;20:276-83.

(12). Barrera R, Ferro C, Navarro JC, Freier J, Liria J, Salas R, et al. Contrasting sylvatic foci of Venezuelan equine encephalitis virus in northern South America. Am J Trop Med Hyg. 2002;67:324-34.

(13.) Fernandez-Badillo A, Guerrero R, Lord R, Ochoa J, Ulloa G Mamiferos de Venezuela. Lista y Claves para su identificacion. Museo de Zoologia Agricola (MIZA-UCV), FAGRO. Caracas: Universidad Central de Venezuela; 1988.

(14). Eisenberg JF. Mammals of the nentropics, Vol. 1. The northern neotropics. Vol. 1. Chicago: University of Chicago Press; 1989.

(15). Chamberlain R, Sudia D. Methods for study of mosquitoes as virus hosts and vectors. Methods Virol. 1967;1:63-103.

(16.) Lane J. Neotropical Culicidae. Vol. 1. Sao Panlo: Sao Paulo University Press; 1953.

(17.) Sirivanakarn S. A review of the systematics and proposed scheme of internal classification of the New World subgenus Melanoconion of Culex (Diptera: Culicidae). Mosquito Systematics. 1982;14:265-333.

(18.) Pecor JE, Mallampalli VL, Harbach RE, Peyton EL. Catalog and illustrated review of the subgenus Melanoconion of Culex (Diptera: Culicidae). Contributions of the American Entomological Institute (Gainesville). 1992;27:1-228.

(19.) Sallum MAM, Forattini OR Revision of the Spissipes section of Culex (Melanoconion) (Diptera: Culicidae). J Am Mosq Control Assoc. 1996;12:517-600.

(20.) Guimarges JH. 1997. Systematic database of diptera of the Americas south of the United States, family Culicidae. In: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. Sao Pablo, Brazil; 1997.

(21). Roehrig JT, Bolin RA. Monoclonal antibodies capable of distinguishing epizootic from enzootic varieties of subtype I Venezuelan equine encephalitis viruses in a rapid indirect immunofluorescence assay. J Clin Microbiol. 1997;35:1887-90.

(22). Powers AM, Oberste MS, Brault AC, Rico-Hesse R, Schmura SM, Smith JF, et al. Repeated emergence of epidemic/epizootic Venezuelan equine encephalitis from a single genotype of enzootic subtype ID virus. J Virol. 1997;71:6697-705.

(23). Brault AC, Powers AM, Medina G, Wang E, Kang W, Salas RA, et al. Potential sources of the 1995 Venezuelan equine encephalitis subtype IC epidemic. J Virol. 2001;75:5823-32.

(24). Swofford DL. PAUP*. Phylogenetic analysis using parsimony (*and other methods). Version 4. Sunderland (MA): Sinauer Associates; 1998.

(25.) Ronquist F, Huelsenbeck JR MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics. 2003; 19:1572-4.

(26). Brault AC, Powers AM, Chavez CL, Lopez RN, Cachon MF, Gutierrez LF, et al. Genetic and antigenic diversity among eastern equine encephalitis viruses from North, Central, and South America. Am J Trop Med Hyg. 1999;61:57-86.

(27). Wang E, Paessler S, Aguilar PV, Smith DR, Coffey LL, Kang W, et al. A novel, rapid assay for detection and differentiation of serotype-specific antibodies to Venezuelan equine encephalitis complex alphaviruses. Am J Trop Med Hyg. 2005;72:805-10.

(28.) Young NA, Johnson KM, Gauld LW. Viruses of the Venezuelan equine encephalomyelitis complex. Experimental infection of Panamanian rodents. Am J Trop Med Hyg. 1969;18:290-6.

(29.) Coffey LL, Carrara AS, Paessler S, Haynie ML, Bradley RD, Tesh RB, et al. Experimental Everglades virus infection of cotton rats (Sigmodon hispidus). Emerg Infect Dis. 2004; 10:2182-8.

(30.) Walton TE, Johnson KM. Experimental Venezuelan equine encephalomyelitis virus infection of the bovine. Infect Immun. 1972;5:155-9.

(31.) Mendez W, Liria J, Navarro JC, Garcia CZ, Freier JE, Salas R, et al. Spatial dispersion of adult mosquitoes (Diptera: Culicidae) in a sylvatic focus of Venezuelan equine encephalitis virus. J Med Entomol. 2001;38:813-21.

(32.) Kinney RM, Johnson BJ, Welch JB, Tsuchiya KR, Trent DW. The full-length nucleotide sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83. Virology. 1989;170:19-30.

(33.) Kinney RM, Tsuchiya KR, Sneider JM, Trent DW. Molecular evidence for the origin of the widespread Venezuelan equine encephalitis epizootic of 1969 to 1972. J Gen Virol. 1992;73:3301-5.

(34.) Walder R, Suarez OM, Calisher CH. Arbovirns studies in the Guajira region of Venezuela: activities of eastern equine encephalitis and Venezuelan equine encephalitis viruses during an interepizootic period. Am J Trop Med Hyg. 1984;33:699-707.

(35.) Walder R, Suarez OM, Calisher CH. Arbovirus studies in southwestern Venezuela during 1973-1981. II. Isolations and further studies of Venezuelan and eastern equine encephalitis, Una, Itaqui, and Moju viruses. Am J Trop Med Hyg. 1984;33:483-91.

(36.) Estrada-Franco JG, Navarro-Lopez R, Freier JE, Cordova D, Clements T, Moncayo A, et al. Venezuelan equine encephalitis virus, southern Mexico. Emerg Infect Dis. 2004; 10:2113-21.

(37.) Linthicum KJ, Logan TM, Bailey CL, Gordon SW, Peters CJ, Monath TP, et al. Venezuelan equine encephalomyelitis virus infection in and transmission by the tick Amblyomma cajennense (Arachnida: Ixodidae). J Med Entomol. 1991;28:405-9.

(38.) Linthicum KJ, Gordon SW, Mnnath TE Comparative infections of epizootic and enzootic strains of Venezuelan equine encephalomyelitis virus in Amblyomma cajennense (Acari: Ixodidae). J Med Entomol. 1992;29:827-31.

(39.) Linthicum KJ, Logan TM. Laboratory transmission of Venezuelan equine encephalomyelitis virus by the tick Hyalomma truncatum. Trans R Soc Trop Med Hyg. 1994;88:126.

(40.) Sanchez-Vargas 1, Travanty EA, Keene KM, Franz AW, Beaty B J, Blair CD, et al. RNA interference, arthropod-borne viruses, and mosquitoes. Virus Res. 2004;102:65-74.

Juan-Carlos Navarro, * Gladys Medina, ([dagger]) Clovis Vasquez, ([double dagger]) Lark L. Coffey, ([section]) Eryu Wang, ([section]) Alexander Suarez, * ([double dagger]), Hernan Biord, (#) Marlene Salas, ([paragraph]) and Scott C. Weaver ([section])

* Universidad Central de Venezuela, Caracas, Venezuela; ([dagger]) Instituto Nacional de Investigaciones Agropecuarias, Maracay, Venezuela; ([double dagger]) Instituto Nacional de Higiene, Caracas, Venezuela; (#) Sociedad Venezolana de Ciencias Naturales, Venezuela; ([paragraph]) Ministerio de Agricultura y Tierras, Barinas, Venezuela; and ([section]) University of Texas Medical Branch, Galveston, Texas, USA

Address for correspondence: Scott C. Weaver, Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555-0609. USA; fax: 409-747-2415; email:

Dr Navarro is an associate professor in the Universidad Central de Venezuela, Instituto de Zoologia Tropical in Caracas, and also a guest researcher in the University of Texas Medical Branch Center for Biodefense and Emerging Infectious Diseases. His current research interests include vectorborne diseases, mosquito systematics and evolution, and eco-epidemiology of tropical and reemerging arboviruses, mainly VEEV.

Table 1. Results of hemagglutination inhibition assays to

detect Venezuelan equine encephalitis virus antibodies in horses

No. serum No. positive

Municipality samples tested (%)

Obispos 199 46 (23)

Zamora 128 61 (48)

Bolivar 18 0

Pedraza 23 10 (44)

Barinas 172 37 (22)

Arismendi 9 0

Sucre 65 1 (2)

A. Arvelo Torrealba 5 1 (20)

Total 619 174 (28)

Table 2. Serologic results from equines, bovines, and wild

mammals in regions of the 2000 and 2003 VEEV outbreaks *

Dates of No.

Location collection Species or common name collected

Obispos May 2002 Proechimys guairae 10

Zygodontomys brevicauda 47

Zamora May 2003 Akodon urichi 2

Oryzomys talamancae 1

Sigmodon hispidus 13

Zygodontomys brevicauda 1

Didelphis marsupialis 2

Proechimys guairae 18

Rattus rattus 2

Bovines 4

June 2003 Proechimys guairae 6

Sep 2003 Didelphis marsupialis 1

Proechimys guairae 11

Sigmodon hispidus 1

Bovines 20

Nov 2003 Proechimys guairae 10

Sigmodon hispidus 1

Arismendi Oct-Nov 2003 Bovines 48

Antonio Jose June 2003 Proechimys guairae 3

de Sucre/ Didelphis marsupialis 1


Totals Wild mammals 130

Bovines 72

Dates of Fraction HI

Location collection Species or common name seropositive

Obispos May 2002 Proechimys guairae 0/10

Zygodontomys brevicauda 0/47

Zamora May 2003 Akodon urichi 0/2

Oryzomys talamancae 0/1

Sigmodon hispidus 0/13

Zygodontomys brevicauda 0/1

Didelphis marsupialis 0/2

Proechimys guairae 0/18

Rattus rattus 0/2

Bovines 0/4

June 2003 Proechimys guairae 1/6

Sep 2003 Didelphis marsupialis 1/1

Proechimys guairae 4/11

Sigmodon hispidus 1/1

Bovines 0/20

Nov 2003 Proechimys guairae 0/10

Sigmodon hispidus 1/1

Arismendi Oct-Nov 2003 Bovines 12/48

Antonio Jose June 2003 Proechimys guairae 0/3

de Sucre/ Didelphis marsupialis 0/1


Totals Wild mammals 7/130 (5%)

Bovines 12/72 (17%)

Fraction of



Dates of positive

Location collection Species or common name by PRNT

Obispos May 2002 Proechimys guairae NT

Zygodontomys brevicauda NT

Zamora May 2003 Akodon urichi NT

Oryzomys talamancae NT

Sigmodon hispidus NT

Zygodontomys brevicauda NT

Didelphis marsupialis NT

Proechimys guairae NT

Rattus rattus NT

Bovines NT

June 2003 Proechimys guairae 0/1

Sep 2003 Didelphis marsupialis 0/1

Proechimys guairae 0/4

Sigmodon hispidus 0/1

Bovines NT

Nov 2003 Proechimys guairae NT

Sigmodon hispidus NT

Arismendi Oct-Nov 2003 Bovines 8/12

Antonio Jose June 2003 Proechimys guairae NT

de Sucre/ Didelphis marsupialis NT


Totals Wild mammals 0/7

Bovines 8/12

Dates of PRNT

Location collection Species or common name titers

Obispos May 2002 Proechimys guairae NT

Zygodontomys brevicauda NT

Zamora May 2003 Akodon urichi NT

Oryzomys talamancae NT

Sigmodon hispidus NT

Zygodontomys brevicauda NT

Didelphis marsupialis NT

Proechimys guairae NT

Rattus rattus NT

Bovines NT

June 2003 Proechimys guairae <20

Sep 2003 Didelphis marsupialis <20

Proechimys guairae <20

Sigmodon hispidus <20

Bovines NT

Nov 2003 Proechimys guairae NT

Sigmodon hispidus NT

Arismendi Oct-Nov 2003 Bovines 40-640

Antonio Jose June 2003 Proechimys guairae NT

de Sucre/ Didelphis marsupialis NT


Totals Wild mammals <20

Bovines 40-640

* VEEV, Venezuelan equine encephalitis virus, HI,

hemagglutination inhibition, PRINT, plaque reduction

neutralization test; NT, not tested.

Table 3. Results of the blocking ELISA to determine VEEV subtypes

producing seroconversion in HI- and PRNT-positive bovines from

Arismendi municipality, Barinas State, Venezuela *

% inhibition of


MAb 1A3A-5 binding

at indicated serum


Sample no. ([dagger]) 1:4 1:12 1:36

156 3.0 8.5 -5.0

158 12.4 13.9 -3.6

166 35.6 12.5 6.2

167 59.6 42.0 3.7

172 -11.7 -15.4 -13.8

175 8.2 5.0 2.1

178 23.1 15.1 2.2

204 -1.1 -10.8 -22.4

Negative control ([dagger]) 4.1 6.6 5.4

Negative control ([dagger]) 9.4 14.1 12.0

Negative control ([dagger]) 5.8 11.4 11.3

Positive control ([dagger]) 18.8 9.5 -8.0

Positive control ([dagger]) 16.4 1.4 1.7

% inhibition of


MAb 1 A1B-9 binding

at indicated serum


Sample no. ([dagger]) 1:4 1:12 1:36

156 52.4 17.8 -34.3

158 27.0 -20.4 -37.0

166 30.7 42.7 -21.0

167 65.7 17.1 -9.9

172 37.5 32.1 -19.0

175 48.5 21.5 -20.0

178 69.7 44.9 -5.9

204 75.8 56.4 29.7

Negative control ([dagger]) 15.2 23.1 -5.7

Negative control ([dagger]) 8.0 14.5 15.6

Negative control ([dagger]) 17.5 23.2 11.0

Positive control ([dagger]) 65.3 51.0 29.0

Positive control ([dagger]) 50.1 16.7 18.9

* ELISA, enzyme-linked immunosorbent assay; VEEV, Venezuelan

equine encephalitis virus; HI, hemagglutination-inhibition; PRNT,

plaque reduction neutralization test; MAb, monoclonal antibody.

([dagger]) Negative controls are bovine sera from locations

with no history of VEE; positive controls are human sera from

virus isolation-confirmed, subtype ID VEEV infections (note

that the assay is species-independent).

Table 4. Mosquitoes collected in the regions affected by the

2000 and 2003 Venezuelan equine encephalitis outbreaks

Study site

Species Zamora Obispos Arismendi Total

Culex (Melanoconion) dunni 133 924 25 1,082

Cx. (Mel.) spissipes 26 15 41

Cx. (Mel.) pedroi * 1 1

Cx. (Mel.) theobaldi 1 1

Cx. (Mel.) ocossa * 13 6 19

Cx. (Mel.) panocossa * 5 5

Cx. (Mel.) sp. Mel Section 24 120 144

Cx. (Cux.) spp. 800 132 45 977

Psorophora albipes 39 18 57

Ps. ferox 2 5 7

Ps. lineata 1 1

Ps. cingulata 7 3 10

Aedes fulvus ([dagger]) 2 2

Ae. scapularis ([dagger]) 6 44 9 59

Uranotaenia calosomata 17 5 22

Trichoprosopon digitatum 12 1 13

Trichoprosopon sp. 1 1

Wyeomyia (Phoniomyia) sp. 2 2

Uranotaenia geometrica 2 2

Coquillettidia arribalzagae 6 70 76

C. nigricans 5 5

C. juxtamansonia 7 7

Mansonia titillans 10 169 179

Limatus asulleptus 4 4

Aedomyia squamipennis 3 3

Anopheles sp. 2 2

* Proven enzootic vectors of Venezuelan equine encephalitis virus.

([dagger]) Suspected bridge vectors.

Table 5. Sequence comparisons between the year 2000 VEEV virus

equine isolates and those from the 1995 epidemic *


strain State of Horse Date of Passage

([dagger]) isolation sample collection history

254934 Barinas Brain Apr 10, 2000 sm-1

255010 Barinas Serum Feb 20, 2000 sm-2

255005 * Barinas Serum Feb 20, 2000 sm-3

255057 * Carabobo Brain April, 2000 sm-1, V-1

Comparisons to 1995 Comparisons to 1995

strain 6119 strain 3908


Virus differences aa nt aa

strain ([double differences differences differences

([dagger]) dagger]) ([section]) ([paragraph]) #

254934 C1248T — A1443G —

G6325A nsP4/V2081 T4975C

G9165A E2/E199K C5292T —

T10913C — T5475C —

C11237T — G6325A nsP4/V2081

A6498T —

G9159A E2/E199K

C11237T —

255010 C1248T — A1443G —

T10913C — T4975C —

C11237T — C5292T —

T5475C —

A6498T —

G9159A E2/E199K

C11237T —

255005 * 0 — 0 —

255057 * 0 — 0 —

* VEEV, Venezuelan equine encephalitis virus; nt, nucleotide; aa,

amino acid.

([dagger]) Only partial PE2 envelope glycoprotein precursor gene

sequences determined (817 nucleotides).

([double dagger]) Strain 6119 residue is indicated first, followed

by genome position and year 2000 strain residue.

([section]) Strain 6119 residue is indicated first, followed by

protein and amino acid position and year 2000 strain residue.

([paragraph]) Strain 3908 residue is indicated first, followed by

genome position and year 2000 strain residue.

# Strain 3908 residue is indicated first, followed by protein

and amino acid position and year 2000 strain residue.

COPYRIGHT 2005 U.S. National Center for Infectious Diseases

COPYRIGHT 2005 Gale Group